Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curdin Conrad

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|August 4, 2005
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatmentMirjana Urosevic, Reinhard Dummer, Curdin Conrad, et al.
Human Pathology|September 13, 2005
CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotypeMirjana Urosevic, Curdin Conrad, Jivko Kamarashev, et al.
Dermatology and Therapy|March 15, 2024
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical TrialsAlexander Egeberg, Curdin Conrad, Patricia Gorecki, et al.
The Journal of Experimental Medicine|February 26, 2004
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alphaOnur Boyman, Hans Peter Hefti, Curdin Conrad, et al.
Case Reports in Dermatology|April 8, 2014
Purpura of the face and neck: an atypical clinical presentation revealing a hepatosplenic T cell lymphomaFrançois Kuonen, Maya Bucher, Laurence de Leval, et al.
The Journal of Investigative Dermatology|July 18, 2024
A European Roundtable "Addressing Under-Prioritized Skin Diseases: Policy Responses to High-Burden Conditions"Yalchin Mammadov, Jennifer Austin, Tammi Shipowick, et al.
Swiss Medical Weekly|November 20, 2009
Estimation of cost-of-illness in patients with psoriasis in SwitzerlandAlexander A Navarini, Emanuel Laffitte, Curdin Conrad, et al.
Revue Medicale Suisse|October 19, 2022
[Janus kinase inhibitors : new perspectives for precision medicine ?]Jérémie Tachet, Alexandre Dumusc, Curdin Conrad, et al.
Archives of Dermatology|December 22, 2004
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursorsMichel Gilliet, Curdin Conrad, Michael Geiges, et al.
The Journal of Allergy and Clinical Immunology|January 20, 2016
Targeting CD8(+) T cells prevents psoriasis developmentPaola Di Meglio, Federica Villanova, Alexander A Navarini, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|August 4, 2005
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatmentMirjana Urosevic, Reinhard Dummer, Curdin Conrad, et al.
Human Pathology|September 13, 2005
CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotypeMirjana Urosevic, Curdin Conrad, Jivko Kamarashev, et al.
Dermatology and Therapy|March 15, 2024
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical TrialsAlexander Egeberg, Curdin Conrad, Patricia Gorecki, et al.
The Journal of Experimental Medicine|February 26, 2004
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alphaOnur Boyman, Hans Peter Hefti, Curdin Conrad, et al.
Case Reports in Dermatology|April 8, 2014
Purpura of the face and neck: an atypical clinical presentation revealing a hepatosplenic T cell lymphomaFrançois Kuonen, Maya Bucher, Laurence de Leval, et al.
The Journal of Investigative Dermatology|July 18, 2024
A European Roundtable "Addressing Under-Prioritized Skin Diseases: Policy Responses to High-Burden Conditions"Yalchin Mammadov, Jennifer Austin, Tammi Shipowick, et al.
Swiss Medical Weekly|November 20, 2009
Estimation of cost-of-illness in patients with psoriasis in SwitzerlandAlexander A Navarini, Emanuel Laffitte, Curdin Conrad, et al.
Revue Medicale Suisse|October 19, 2022
[Janus kinase inhibitors : new perspectives for precision medicine ?]Jérémie Tachet, Alexandre Dumusc, Curdin Conrad, et al.
Archives of Dermatology|December 22, 2004
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursorsMichel Gilliet, Curdin Conrad, Michael Geiges, et al.
The Journal of Allergy and Clinical Immunology|January 20, 2016
Targeting CD8(+) T cells prevents psoriasis developmentPaola Di Meglio, Federica Villanova, Alexander A Navarini, et al.
Pageof 12